Global Rapid RNA Testing Kit Market Size To Exceed USD 12.16 Billion By 2035 | CAGR Of 14.1%

Category: Healthcare

RELEASE DATE Oct 2025
REPORT ID SI16118

Global Rapid RNA Testing Kit Market To Exceed USD 12.16 Billion By 2035

According to a research report published by Spherical Insights & Consulting, The Global Rapid RNA Testing Kit Market Size is Expected To Grow from USD 2.85 Billion in 2024 to USD 12.16 Billion by 2035, at a CAGR of 14.1% during the forecast period 2025-2035.

Get more details on this report -

Request Free Sample PDF

 

Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the" Global Rapid RNA Testing Kit Market Size, Share, and COVID-19 Impact Analysis, By Product Type (PCR-based Kits, Isothermal Amplification Kits, CRISPR-based Kits, and Others), By Application (Clinical Diagnostics, Research, Forensic Testing, and Others), By Distribution Channel (Online Stores, Pharmacies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035."Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/rapid-rna-testing-kit-market       

   

The Rapid RNA Test Kit Market Size involves in rapidly growing, fueled by rising RNA virus infections like COVID-19, influenza, and RSV. These kits enable fast, accurate diagnosis, critical for outbreak control and timely treatment. Demand for decentralized, point-of-care, and home-based testing is increasing, driven by the need for quick healthcare delivery. Innovations such as CRISPR, isothermal amplification (e.g., LAMP), and lab-on-a-chip platforms have improved speed, sensitivity, and portability. The COVID-19 pandemic accelerated the adoption of rapid RNA tests, making them a key tool in clinical and emergency settings. Beyond human health, opportunities lie in veterinary, agricultural, and environmental diagnostics. With global emphasis on pandemic preparedness and public health surveillance, rapid RNA test kits are set for continued growth as essential tools in early detection and response. Their expanding role strengthens healthcare access in both urban and remote areas. High costs, limited low-resource access, and the need for skilled operators constrain rapid RNA testing growth.

 

The PCR-based kits segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the form, the rapid RNA testing kit market is divided into PCR-based kits, isothermal amplification kits, CRISPR-based kits, and others. Among these, the PCR-based kits segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Renowned for their precision, sensitivity, and dependability, these kits are considered the benchmark in RNA testing. Rising cases of infectious diseases and genetic disorders drive demand, highlighting their role in accurate and early diagnosis.

 

The clinical diagnostics segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the application, the rapid RNA testing kit market is divided into clinical diagnostics, research, forensic testing, and others. Among these, the clinical diagnostics segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. RNA testing kits play a vital role in clinical environments by enabling rapid pathogen detection and guiding treatment strategies. Increasing chronic disease cases and the push for personalized medicine are strengthening demand for clinical diagnostics.

 

The online stores segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the distribution channel, the rapid RNA testing kit market is divided into online stores, pharmacies, and others. Among these, the online stores segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Online stores are gaining popularity due to diverse product options, competitive prices, and home delivery services. The COVID-19 pandemic further boosted online adoption as consumers and healthcare providers preferred safe, contactless purchasing methods.

 

Get more details on this report -

Request Free Sample PDF

 

North America is expected to hold the majority share of the global rapid RNA testing kit market during the forecast period.

North America is expected to hold the majority share of the global rapid RNA testing kit market during the forecast period. Market growth in the region is driven by a strong healthcare infrastructure, widespread use of advanced diagnostic tools, and substantial R&D investments. The presence of leading industry players and a rise in chronic and infectious diseases also contribute to the growing demand for RNA testing kits.

 

Get more details on this report -

Request Free Sample PDF

 

Asia Pacific is anticipated to grow at the fastest pace in the global rapid RNA testing kit market during the forecast period. The region’s developing healthcare infrastructure, rising medical spending, and heightened awareness of early disease detection are major growth drivers. Emerging markets such as China and India are making substantial investments in healthcare and diagnostics, offering strong opportunities for RNA test kit producers.

 

Major vendors in the global rapid RNA testing kit market are Thermo Fisher Scientific, QIAGEN, Danaher, Abbott Laboratories, Roche Diagnostics, Merck KGaA, Quidel Corporation, Hologic, Bio-Rad Laboratories, PerkinElmer, Luminex Corporation, BD (Becton Dickinson), Agilent Technologies, and Others.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Key Market Development 

  • In July 2024, Bio-Rad Laboratories highlighted advances in its Droplet Digital PCR solutions, including strategic collaborations with oncology centers to improve cancer patient monitoring and expanding its product portfolio to support growing Droplet Digital PCR use in biopharma and translational research markets.

 

  • In February 2021, PerkinElmer launched the COVID-19 Antigen Test for detecting SARS-CoV-2 nucleocapsid protein in nasal or nasopharyngeal swabs. The rapid lateral flow test provides results in 15 minutes, aiding diagnosis and screening in symptomatic and asymptomatic individuals.            

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the rapid RNA testing kit market based on the below-mentioned segments:

 

Global Rapid RNA Testing Kit Market, By Product Type  

  • PCR-based Kits                                               
  • Isothermal Amplification Kits                                                   
  • CRISPR-based Kits                                                        
  • Others

 

Global Rapid RNA Testing Kit Market, By Application

  • Clinical Diagnostics                                                      
  • Research                                                          
  • Forensic Testing                                             
  • Others

 

Global Rapid RNA Testing Kit Market, By Distribution Channel   

  • Online Stores                                                  
  • Pharmacies                                                     
  • Others

 

 Global Rapid RNA Testing Kit Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies